Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Therapies

The Panel reviews the most recent clinical data to develop treatment recommendations for clinicians who are caring for patients with COVID-19.

Statement on Casirivimab Plus Imdevimab EUA

Read the Panel’s statement on the EUA of casirivimab plus imdevimab for the treatment of COVID-19.

Statement on Anti-SARS-CoV-2 Monoclonal Antibodies EUA

Read the Panel’s statement on the FDA EUAs of anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19.

Antiviral Therapy

These sections summarize the data on remdesivir, chloroquine, and other antiviral medications.

Anti-SARS-CoV-2 Antibody Products

These sections summarize the data on monoclonal antibodies, convalescent plasma, and SARS-CoV-2 immunoglobulins.

Cell-Based Therapy

Review the data on the use of mesenchymal stem cells for the treatment of COVID-19.

Immunomodulators

These sections summarize the data on IL-6 inhibitors, kinase inhibitors, and other immunomodulators.

Antithrombotic Therapy

This section discusses screening, prevention, and treatment for thromboembolism in people with COVID-19.

Concomitant Medications

Review the data on using certain concomitant therapies in people with COVID-19.

Supplements

These sections discuss the rationale for using supplements in people with COVID-19.